Open AccessTrue Resistant Hypertension Following Observed Drug Ingestion: A Systematic Evaluation
Author(s) -
Bunker Jill,
Chang ChoonLan,
Chapman Neil,
Poulter Neil,
Thom Simon,
ThorntonJones Lucy,
Sever Peter
Publication year - 2017
Publication title -
the journal of clinical hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.909
H-Index - 67
eISSN - 1751-7176
pISSN - 1524-6175
DOI - 10.1111/jch.12896
Subject(s) - medicine , ingestion , ambulatory , drug , ambulatory blood pressure , referral , pharmacology , family medicine
The authors investigated the role of poor drug adherence in treatment‐resistant hypertension following observed drug ingestion in 102 patients. Median blood pressures ( BP s) were 170/91 mm Hg at referral, 153/84 mm Hg prior to, and 142/79 mm Hg during a 4‐ to 6‐hour period after drug ingestion. Median daytime ambulatory BP monitoring ( ABPM ) over the following 24 hours was 142/80 mm Hg. Median BP at a final follow‐up clinic visit was 147/79 mm Hg. The cumulative number of patients achieving a goal of <140/90 mm Hg in clinic or <135/85 mm Hg mean on ABPM was 57 (56%), with a further nine (9%) controlled at the final follow‐up clinic visit. Thus, 65% of patients achieved a systolic BP <140 mm Hg at any point immediately prior to, or after, drug ingestion; the residual 35% were considered to have true resistant hypertension. In conclusion, among patients with suspected resistant hypertension, a minority were truly treatment‐resistant following observed drug ingestion and BP monitoring.